Events Calendar

Improving MDS Outcomes from Diagnosis to Treatment: A Multidisciplinary Approach

Wednesday, October 18, 2017

8:00 AM–2:30 PM
Dallas Marriott Suites Medical/Market Center
2493 North Stemmons Freeway
Boston, Massachusetts

register


Hosted in partnership by: American Society for Hematology (ASH), American Society for Clinical Pathology (ASCP), and The France Foundation

Educational Supporters: Funded by an independent educational grant from Celgene Corporation.

Agenda and Faculty
The goal of this summit is to improve performance diagnosis and treatment of MDS patients. Participants will actively engage in multidisciplinary, interactive small-group activities, including:

  • Case-based tumor board discussions
  • Identifying the new role of molecular testing
  • Distinguishing morphologic mimics from MDS
  • Assessing low and high grade MDS
  • Applying the new prognostic scoring system to patients

Summit Steering Committee
Dita Gratzinger, MD, PhD (Chair)
Stanford, CA

Mikkael Sekeres, MD, MS
Cleveland, OH

Marilyn Slovak, PhD, FACMG
Albuquerque, NM

David Steensma, MD
Boston, MA

Sa Wang, MD
Houston, TX

The American Society for Clinical Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The ASCP designates this live event for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.

Location 
Dallas Marriott Suites Medical/Market Center

2493 North Stemmons Freeway
Dallas, TX, 75207
(214) 905-0050
Location Website

Back

Updates

Upcoming Events

No events

Featured Online Activities